Asia Pacific Preterm Labor Treatment Market Size, Share, Growth, Trends and Industry Analysis: By Drugs, By Dosage Form, By End user and Country Forecast 2020-2031
Asia Pacific Preterm Labor Treatment Market size was valued at US$ 579.25 million in 2024 and is expected to reach US$ 1,045.37 million by 2031, growing at a significant CAGR of 8.8% from 2025-2031. Increase in technological advancements, increasing demand for preterm therapeutics and diagnostics, increase in support of government, increase in R&D investments by market players are expected to propel the growth of preterm labor treatment market. However, lack of awareness, stringent regulatory framework, high costs associated with the treatment will hamper the growth of preterm labor treatment market.
Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market. As per WHO statistics, every year 15Mn babies are born.
Asia Pacific preterm labor treatment market is divided into countries, Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea and Rest of Asia-Pacific. Asia Pacific is anticipated to show significant growth in preterm labor treatment market owing to increase in awareness coupled with disposable income of developing economies, growing population pool. Increase incidences in the preterm births enables propel the growth of preterm labor treatment market in Asia Pacific. Rise in participation of public and private establishments in organizing awareness programs regarding the child birth, pregnancy, preterm birth further enhance the demand for preterm labor treatment.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Market Size in 2024 |
US$ 579.25 million |
|
Market Size in 2031 |
US$ 1,045.37 million |
|
By Drugs Type |
|
|
By Dosage form |
|
|
By End User |
|
Download Free Sample Report
Asia Pacific preterm labor treatment market size was valued at US$ 579.25 million in 2024 and is expected to reach US$ 1,045.37 million by 2031, growing at a significant CAGR of 8.8% from 2025-2031.
The report covers the market data: China, India, Japan, Australia & New Zealand
The market key players are Pfizer, Novartis, Merck & Co, Sanofi, Johnson and Johnson, GlaxoSmithKline, AstraZeneca, Cipla
| 1.Executive Summary |
| 2. Asia Pacific Preterm Labor Treatment Market Introduction |
| 2.1. Asia Pacific Preterm Labor Treatment Market - Taxonomy |
| 2.2. Asia Pacific Preterm Labor Treatment Market - Definitions |
| 2.2.1.Drugs Type |
| 2.2.2.Dosage form |
| 2.2.3.End User |
| 2.2.4.Country |
| 3. Asia Pacific Preterm Labor Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Asia Pacific Preterm Labor Treatment Market Analysis, 2020-2024 and Forecast 2024-2031 |
| 4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Asia Pacific Preterm Labor Treatment Market By Drugs Type, 2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 5.1. Tocolytic Drugs |
| 5.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Beta Mimetic |
| 5.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Calcium Channel Blockers |
| 5.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. NSAIDS |
| 5.4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Corticosteroids |
| 5.5.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Magnesium Sulphate |
| 5.6.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Antibiotics |
| 5.7.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Others |
| 5.8.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6. Asia Pacific Preterm Labor Treatment Market By Dosage form, 2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 6.1. Tablets |
| 6.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Capsules |
| 6.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Injection |
| 6.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Asia Pacific Preterm Labor Treatment Market By End User, 2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pediatric and Neonatal Clinics |
| 7.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Nursing Homes |
| 7.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Pharmacy |
| 7.4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Asia Pacific Preterm Labor Treatment Market By Country, 2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 8.1. China |
| 8.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. India |
| 8.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Australia and New Zealand (ANZ) |
| 8.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Japan |
| 8.4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Rest of APAC |
| 8.5.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.China Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 9.1. Drugs Type Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Tocolytic Drugs |
| 9.1.2.Beta Mimetic |
| 9.1.3.Calcium Channel Blockers |
| 9.1.4.NSAIDS |
| 9.1.5.Corticosteroids |
| 9.1.6.Magnesium Sulphate |
| 9.1.7.Antibiotics |
| 9.1.8.Others |
| 9.2. Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Tablets |
| 9.2.2.Capsules |
| 9.2.3.Injection |
| 9.3. End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Pediatric and Neonatal Clinics |
| 9.3.3.Nursing Homes |
| 9.3.4.Pharmacy |
| 10.India Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 10.1. Drugs Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Tocolytic Drugs |
| 10.1.2.Beta Mimetic |
| 10.1.3.Calcium Channel Blockers |
| 10.1.4.NSAIDS |
| 10.1.5.Corticosteroids |
| 10.1.6.Magnesium Sulphate |
| 10.1.7.Antibiotics |
| 10.1.8.Others |
| 10.2. Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Tablets |
| 10.2.2.Capsules |
| 10.2.3.Injection |
| 10.3. End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Pediatric and Neonatal Clinics |
| 10.3.3.Nursing Homes |
| 10.3.4.Pharmacy |
| 11.Australia and New Zealand (ANZ) Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 11.1. Drugs Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Tocolytic Drugs |
| 11.1.2.Beta Mimetic |
| 11.1.3.Calcium Channel Blockers |
| 11.1.4.NSAIDS |
| 11.1.5.Corticosteroids |
| 11.1.6.Magnesium Sulphate |
| 11.1.7.Antibiotics |
| 11.1.8.Others |
| 11.2. Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Tablets |
| 11.2.2.Capsules |
| 11.2.3.Injection |
| 11.3. End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Pediatric and Neonatal Clinics |
| 11.3.3.Nursing Homes |
| 11.3.4.Pharmacy |
| 12.Japan Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 12.1. Drugs Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Tocolytic Drugs |
| 12.1.2.Beta Mimetic |
| 12.1.3.Calcium Channel Blockers |
| 12.1.4.NSAIDS |
| 12.1.5.Corticosteroids |
| 12.1.6.Magnesium Sulphate |
| 12.1.7.Antibiotics |
| 12.1.8.Others |
| 12.2. Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Tablets |
| 12.2.2.Capsules |
| 12.2.3.Injection |
| 12.3. End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Pediatric and Neonatal Clinics |
| 12.3.3.Nursing Homes |
| 12.3.4.Pharmacy |
| 13.Rest of APAC Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million) |
| 13.1. Drugs Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Tocolytic Drugs |
| 13.1.2.Beta Mimetic |
| 13.1.3.Calcium Channel Blockers |
| 13.1.4.NSAIDS |
| 13.1.5.Corticosteroids |
| 13.1.6.Magnesium Sulphate |
| 13.1.7.Antibiotics |
| 13.1.8.Others |
| 13.2. Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Tablets |
| 13.2.2.Capsules |
| 13.2.3.Injection |
| 13.3. End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Pediatric and Neonatal Clinics |
| 13.3.3.Nursing Homes |
| 13.3.4.Pharmacy |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Pfizer |
| 14.2.2.Novartis |
| 14.2.3.Merck & Co |
| 14.2.4.Sanofi |
| 14.2.5.Johnson and Johnson |
| 14.2.6.GlaxoSmithKline |
| 14.2.7.AstraZeneca |
| 14.2.8.Cipla |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
